Legal Representation
Attorney
A. Reagan Fibbe
USPTO Deadlines
Next Deadline
57 days remaining
NOA E-Mailed - SOU Required
Due Date
February 12, 2026
Extension Available
Until August 12, 2026
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 12, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 17, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 17, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 11, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 13, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 12, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 12, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 12, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 10, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 10, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 10, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 16, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 1, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for cell therapy; cells and cell lines for medical or clinical use; cellular pharmaceutical preparations for use in oncology; natural killer (NK) cell preparations for clinical use, medical use, and laboratory use; pharmaceutical preparations in the nature of cells and viral systems comprised of viral vectors used to deliver modified genetic material into other cells for medical purposes; kits comprised of cell-derived preparations, namely, natural killer cell and other immune cell-derived preparations for clinical, medicinal, and therapeutic use
Class 042
Medical and scientific research; cell therapy research and development; scientific and technological services, namely, research, analysis and testing in the field of oncology, cell therapy, and immuno-oncology
Class 045
Licensing of intellectual property
Classification
International Classes
005
042
045